A world leader
  in patient-centered care

 

Translating the next generation
  of cancer researchers

 

The most advanced
  treatment options available

 

Testing for BRCA mutations reaches high levels among young women with breast cancer, study finds

February 11, 2016

In a new study, Dana-Farber researchers find that BRCA1 and BRCA2 testing for young women with breast cancer reaches new high levels. Results of these genetic tests are increasingly used to guide treatment and many who don’t carry such mutations still opt for bilateral mastectomy.

Discover Care Believe - boy on pier

"Discover. Care. Believe." highlights Dana-Farber breakthroughs

Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.

Website
Video
What do you #DiscoverCareBelieve?

Researcher

New online resource for precision cancer medicine

Clinicians at Dana-Farber/Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.

Alternative proteins encoded by the same gene have widely divergent functions in cells
February 11, 2016

In a first large-scale systematic study led by researchers at Dana-Farber, scientists found that most sibling proteins – known as "protein isoforms" encoded by the same gene – often play radically different roles within tissues and cells, however alike they may be structurally.

Dana-Farber Cancer Institute at St. Elizabeth's Medical Center names Christopher Lathan, MD, as Medical Director
February 10, 2016

Christopher Lathan, MD, MS, MPH, is the new medical director of Dana-Farber Cancer Institute at St. Elizabeth's Medical Center. The partnership between Dana-Farber and St. Elizabeth's enables patients to receive the benefit of Dana-Farber's advances in care and research at their local hospital.

Dana-Farber to study ways to reduce overtreatment of DCIS
February 05, 2016

Dana-Farber investigators receive $13.3 million in funding to study whether some groups of patients with DCIS who do not benefit from standard treatment, could be effectively managed with surveillance alone.

Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma
February 01, 2016

Dana-Farber Cancer Institute today announced an immuno-oncology collaboration with potential applicability in a wide range of oncology indications with Array BioPharma.

More Young Women With Breast Cancer Seeking Genetic Testing, Study Finds (US News & World Report)

February 12, 2016

Dr. Ann Partridge led a study showing testing for BRCA1 and BRCA2 gene mutations, which significantly increase a woman’s risk of getting breast cancer and ovarian cancer, is on the rise among women ages 40 and under who’ve been diagnosed with breast cancer.

Dana-Farber Joins Coalition Calling for Better HPV Vaccination Rates (Boston Magazine)
February 01, 2016

Dana-Farber is one of 70 top cancer centers nationwide releasing a joint statement encouraging HPV vaccinations.

Two Studies Explore Clinical Utility of Tumor Sequencing in Pediatric Oncology (Genome Web)
January 28, 2016

Dr. Katherine Janeway led a study finding some pediatric cancer patients harbor mutations in their tumor or germline that have potential clinical significance, either for diagnosis or treatment.

Calls intensify to get Medicare to pay for genetic sequencing of tumors (Boston Globe/STAT)
January 26, 2016

Dr. George Demetri comments on the call for Medicare and Medicaid to pay for advanced gene-sequencing of tumors.

Christopher J. Recklitis, PhD, MPH, on Fatigue and Sleep Disturbances (ASCO Post)
January 20, 2016

Dr. Christopher Recklitis commented on patient issues as part of the 2016 cancer survivorship symposium in San Francisco.

Families give insights into end-of-life choices (CBS News)
January 20, 2016

Dr. Alexi Wright led a study showing families of terminally ill cancer patients say end-of-life care is better when the patient is at home or in hospice care, not in the hospital intensive care unit.

VP Bidens fight to find cancer cure (MSNBC)
January 19, 2016

Dr. George Demetri discusses the moonshot initiative to conquer cancer.

Opinion: What A Cancer Cure ‘Moon Shot’ Might Look Like (WBUR-Radio)
January 14, 2016

Dr. Barrett Rollins talks about President Obama's new national effort called "moon shot" to help in the fight against cancer.

Energize Your Feet

February 15, 2016

9:30 AM - 10:00 AM

Smith Building, Room 330

This is a 30 minute class that focuses on your feet and calf muscles. Learn how to stretch and strengthen these muscles and walk out feeling grounded and lighter on your feet.

Contact the Leonard P. Zakim Center for Integrative Therapies for any questions: 617-632-3322 or Zakim_Center@dfci.harvard.edu.

more

Chair Pilates

February 15, 2016

10:15 AM - 11:00 AM

Smith Building, Room 330

This is a 45 minute class where you will experience Pilates using a chair. This class is open to all cancer patients, family members and staff. If you are unable to get to the floor, or want to learn core strengthening exercises that can be done at your desk, this class is for you.

Contact the Leonard P. Zakim Center for Integrative Therapies for any questions: 617-632-3322 or email Zakim_Center@dfci.harvard.edu.

more

Pilates Mat Class(1)

February 15, 2016

11:15 AM - 12:00 PM

Smith Building, Room 330

This is a 45 minute class where you can learn how to strengthen your core using the basic principles of Pilates. The class is open to all cancer patients, families and staff. No sneakers for this class. Registration is required for this class and patients will need medical clearance from their physician. Contact the Leonard P. Zakim Center for Integrative Therapies to register, or for any questions: 617-632-3322 or email Zakim_Center@dfci.harvard.edu. more

  •  
  • Patient referral information, clinical resources and more.

  • Make an Appointment


    For adults:
    877-442-3324

    Quick access: Appointments as soon as the next day for new adult patients

    For children:
    888-733-4662


    Request Appointment Online

  • Clinical Trials

    Search current cancer clinical trials at Dana-Farber.

  • How to Help

    Yawkey Center for Cancer Care entrance

    There are many ways to support Dana-Farber and the Jimmy Fund.

    give now button
  • Top-ranked

    • U.S. News Best Hospitals Cancer 2015-2016 logo    U.S. News Best Children's Hospitals Cancer 2015-2016 logo 

    Top-ranked cancer center in New England for adults (with Brigham and Women's Hospital) — #1 in the nation for children (with Boston Children's Hospital)

  • Dana-Farber Blog

    Insight Blog screenshot

    Insight features the latest in cancer care and research news from Dana-Farber.
    Read the blog

  • Dana-Farber eNewsletter

    Dana-Farber Spotlight

    Stay current on the latest news by signing up for Spotlight, our email newsletter.
    View current issue
    Subscribe now